Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

An Artificial Intelligence (AI) Approach for Automated Flow Cytometric Diagnosis of B-Cell Lymphoma

Alexander Höllein, MD, Max Zhao, Richard Schabath, MD, Torsten Haferlach, MD, Claudia Haferlach, MD, Peter Krawitz, MD, Wolfgang Kern, MD

Blood (2018) 132 (Supplement 1): 2856.

https://doi.org/10.1182/blood-2018-99-113797

Published: 2018

Journal Articles

Identification and Characterization of Potential Candidates for Treatment Targeting Apoptosis Pathways in Patients with Hematological Neoplasms

Claudia Haferlach, MD, Wencke Walter, PhD, Alexander Höllein, MD, Niroshan Nadarajah, Wolfgang Kern, MD, Manja Meggendorfer, PhD, Torsten Haferlach, MD

Blood (2018) 132 (Supplement 1): 4098.

https://doi.org/10.1182/blood-2018-99-117927

Published: 2018

Journal Articles

Using Whole Genome Sequencing (WGS) of 3256 Patients with Hematologic Malignancies to Determine Genome Instability

Constance Baer, PhD, Stephan Hutter, PhD, Alexander Höllein, MD, Wencke Walter, PhD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2018) 132 (Supplement 1): 3943.

https://doi.org/10.1182/blood-2018-99-116188

Published: 2018

Journal Articles

NPM1 Mutated AML Is Characterized By Pre-Leukemic Mutations and the Persistence and Acquisition of Co-Mutations in Molecular Remission Leads to Inferior Prognosis

Luca Vincenzo Cappelli, MD, Manja Meggendorfer, PhD, Constance Baer, PhD, Niroshan Nadarajah, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD, Alexander Höllein, MD

Blood (2018) 132 (Supplement 1): 996.

https://doi.org/10.1182/blood-2018-99-118286

Published: 2018

Journal Articles

Whole Genome Sequencing and RNA Sequencing of 27 Patients with Persistent Polyclonal B-Cell Lymphocytosis Reveals a High Mutation Frequency/Overexpression of Lymphoma Associated Genes: Really a Benign Disorder?

Anna Stengel, PhD, Alexander Höllein, MD, Wolfgang Kern, MD, Manja Meggendorfer, PhD, Claudia Haferlach, MD, Wencke Walter, PhD, Stephan Hutter, PhD, Torsten Haferlach, MD

Blood (2018) 132 (Supplement 1): 924.

https://doi.org/10.1182/blood-2018-99-111480

Published: 2018

Journal Articles

WGS and RNA-Seq Is Superior to Conventional Diagnostic Tests in Multiple Myeloma: Ready for Prime Time?

Alexander Höllein, MD, Sven O. Twardziok, PhD, Wencke Walter, PhD, Stephan Hutter, PhD, Jesús María Hernández, Manja Meggendorfer, PhD, Torsten Haferlach, MD, Wolfgang Kern, MD, Claudia Haferlach, MD

Blood (2018) 132 (Supplement 1): 4442.

https://doi.org/10.1182/blood-2018-99-113371

Published: 2018

Journal Articles

DNMT3A and NPM1 Double Mutated AML Is a Phenomenon of the Younger Patient and Could Represent a New Entity

Luca Vincenzo Cappelli, MD, Manja Meggendorfer, PhD, Frank Dicker, PhD, Sabine Jeromin, PhD, Stephan Hutter, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD, Alexander Höllein, MD

Blood (2018) 132 (Supplement 1): 2803.

https://doi.org/10.1182/blood-2018-99-113452

Published: 2018

Journal Articles

Therapy-Related Myeloid Neoplasms (tMN) Following Treatment of Acute Myeloid Leukemia (AML): Exome Sequencing Reveals the Presence of an Ancestral Clone Refractory to Chemotherapy

Luise Hartmann, PhD, Niroshan Nadarajah, Manja Meggendorfer, PhD, Alexander Höllein, MD, Calogero Vetro, MD, Anna Stengel, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2018) 132 (Supplement 1): 1462.

https://doi.org/10.1182/blood-2018-99-112924

Published: 2018

Journal Articles

In Depth Molecular Characterization of AML with RUNX1-RUNX1T1 at Diagnosis and Relapse

Alexander Höllein, MD, Niroshan Nadarajah, Manja Meggendorfer, PhD, Annette Fasan, PhD, Sabine Jeromin, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2017) 130 (Supplement 1): 1416.

https://doi.org/10.1182/blood.V130.Suppl_1.1416.1416

Published: 2017

Journal Articles

NPM1 Mutated AML Can Relapse with Wildtype NPM1 and Evolve with Novel Mutations: Implications for Pathobiology and MRD Monitoring

Alexander Höllein, MD, Manja Meggendorfer, PhD, Annette Fasan, PhD, Frank Dicker, PhD, Sabine Jeromin, PhD, Niroshan Nadarajah, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2017) 130 (Supplement 1): 1417.

https://doi.org/10.1182/blood.V130.Suppl_1.1417.1417

Published: 2017

Journal Articles

Deletion 7q Is Associated with KLF2 and NOTCH2 Mutations and Is Strongly Correlated with Splenic Marginal Zone Lymphoma but Also Found in Lymphoplasmacytic Lymphoma and Hairy Cell Leukemia Variant

Alexander Höllein, MD, Anna Stengel, PhD, Manja Meggendorfer, PhD, Annette Fasan, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2017) 130 (Supplement 1): 1465.

https://doi.org/10.1182/blood.V130.Suppl_1.1465.1465

Published: 2017

NARROW

An Artificial Intelligence (AI) Approach for Automated Flow Cytometric Diagnosis of B-Cell Lymphoma

Identification and Characterization of Potential Candidates for Treatment Targeting Apoptosis Pathways in Patients with Hematological Neoplasms

Using Whole Genome Sequencing (WGS) of 3256 Patients with Hematologic Malignancies to Determine Genome Instability

NPM1 Mutated AML Is Characterized By Pre-Leukemic Mutations and the Persistence and Acquisition of Co-Mutations in Molecular Remission Leads to Inferior Prognosis

Whole Genome Sequencing and RNA Sequencing of 27 Patients with Persistent Polyclonal B-Cell Lymphocytosis Reveals a High Mutation Frequency/Overexpression of Lymphoma Associated Genes: Really a Benign Disorder?

WGS and RNA-Seq Is Superior to Conventional Diagnostic Tests in Multiple Myeloma: Ready for Prime Time?

DNMT3A and NPM1 Double Mutated AML Is a Phenomenon of the Younger Patient and Could Represent a New Entity

Therapy-Related Myeloid Neoplasms (tMN) Following Treatment of Acute Myeloid Leukemia (AML): Exome Sequencing Reveals the Presence of an Ancestral Clone Refractory to Chemotherapy

In Depth Molecular Characterization of AML with RUNX1-RUNX1T1 at Diagnosis and Relapse

NPM1 Mutated AML Can Relapse with Wildtype NPM1 and Evolve with Novel Mutations: Implications for Pathobiology and MRD Monitoring

Deletion 7q Is Associated with KLF2 and NOTCH2 Mutations and Is Strongly Correlated with Splenic Marginal Zone Lymphoma but Also Found in Lymphoplasmacytic Lymphoma and Hairy Cell Leukemia Variant

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only